Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
Pipeline Report
OncClub
All Oncology News
Pipeline Report
Media
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Presentations
Sponsored
Interactive Tools
Learning Modules
Presentations
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Emerging Therapies in HER 2-Positive Metastatic Breast Cancer
EP. 1: Evolving Landscape of HER2-Targeted Therapy in Breast Cancer
January 11th 2020
EP. 2: Adjuvant Strategies in Early-Stage HER2+ Breast Cancer
January 11th 2020
EP. 3: Impact of the KATHERINE Trial on Early-Stage HER2+ BC
January 11th 2020
EP. 4: Early-Stage HER2+ Breast Cancer: The ATEMPT Trial
January 11th 2020
EP. 5: Overview of Neoadjuvant Therapy in HER2+ Breast Cancer
January 11th 2020
EP. 6: HER2+ BC: Selection and Management of Neoadjuvant Therapy
January 11th 2020
EP. 7: Treatment Strategies for Relapsed/Refractory HER2+ mBC
January 11th 2020
EP. 8: Unmet Needs in the Management of HER2+ mBC
January 11th 2020
EP. 9: HER2+ Breast Cancer: Evolution of Antibody-Drug Conjugates
January 11th 2020
EP. 10: HER2+ mBC: Study Design and Results of DESTINY-Breast01
January 11th 2020
NEXT PAGE
<
1
2
>
PREVIOUS PAGE